Skip to content

Rennova Health, Inc.

Delisted

CIK 931059fmd_1C9MWV2YQAEWZE0PNJPZ4ZX3E8Services · Services-General Medical & Surgical Hospitals, NECTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2023, 55 periods

Income Statement · Annual · Millions · USD
Line itemFY2015FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023
Total revenues–18–31516731319
Cost of revenue–911121512578
Gross profit0––231(5)0611
Realized investment gains (losses)–––––––––(1)
Research and development0–––––––––
Selling, general and administrative–31191715–––––
Total operating expenses–6426192832––––
Operating income–(45)(22)(16)(13)(16)(17)(13)(1)1
Interest expense–369–1062––
Other non-operating income (expense)–0(1)(34)0(31)(2)7(2)(2)
Income before taxes(5)–––(13)(47)(19)(5)(3)(0)
Income tax expense–(9)(1)11–(1)000
Net income from continuing operations(5)–(23)(51)(14)(47)(18)(5)(3)(1)
Net income–(38)(33)(55)(14)(48)(18)6(3)(8)
Net income to common shareholders–(38)(33)(109)(246)(172)(282)(501)(334)(8)
Rennova Health, Inc. financial statements · FinancialMD